The implementation of artificial intelligence (AI) assistance in pathology has been shown to significantly reduce the risk of immunohistochemistry (IHC) use per detected case of sentinel node (SN) metastasis, resulting in cost savings and time efficiency. In a single-center prospective trial, AI-assisted pathologists spent less time assessing hematoxylin and eosin (HE) slides of SN specimens and had higher sensitivity and negative predictive values for detecting micrometastases and macrometastases. The study also found that AI assistance prevented the use of IHC for detecting micrometastases and reduced the cost of IHC use per detected case of SN metastasis.
AI Assistance in Pathology Reduces Costs and Time
AI-assisted pathologists spent significantly less time assessing HE slides of SN specimens, with an average time of 3 minutes and 41 seconds compared to 6 minutes and 4 seconds for unassisted pathologists.
TOP STORIES
Quantum computing is transforming industries, but it poses significant cybersecurity risks …
A coalition of state attorneys general has opened an investigation into OpenAI …
The U.S. government’s export control directive has forced Anthropic to disable its new AI models, raising questions about regulation and …
SpaceX’s recent deal with Google highlights its shift from aerospace to AI infrastructure …
Google is suing to dismantle the infrastructure behind an alleged massive AI-powered cybercrime operation …
AI usage continues to grow rapidly, even as public sentiment remains skeptical …
